Bone turnover markers during pubertal development: relationships with growth factors and adipocytokines.
The rapid increase in skeletal mass that occurs during puberty is caused by increases in longitudinal growth as well as cortical thickness. The measurement of growth changes during puberty using two-dimensional (dual-energy X-ray absorptiometry) and/or three-dimensional (computed tomography, magnetic resonance imaging) measurement devices provides only a static representation of bone tissue parameters. The measurement of bone turnover markers provides a more dynamic picture of the nature of bone tissue that can be repeated at much shorter intervals during puberty. The bone turnover markers are products of osteoblasts and osteoclasts which can be measured in urine or blood. The increase in different markers of bone turnover coincides with the pubertal growth spurt and thereafter markers decline until they converge into adult values. The initiation of puberty is accompanied by increases in androgens and estrogens. The effects of sex hormones on bone mineral accrual are mediated mainly by growth hormone and insulin-like growth factor-1, but they also exert a direct effect on bone metabolism. Important determinants of bone mineral accrual during puberty include optimal nutritional status, body composition parameters and physical activity pattern. All of these determinants are related to the state of energy balance, while peripheral indicators of energy balance, such as different growth factors and adipocytokines, may also have a positive influence of the growing skeleton. Taken together, bone mineral accrual during puberty is a complex interaction between physical activity pattern, various body composition parameters, specific growth factors and adipocytokines, and also sex hormones.
Jaak
J
Jürimäe
Jarek
J
Mäestu
Toivo
T
Jürimäe
D054392:Adipokines / Q000097:blood* / Q000502:physiology; D000293:Adolescent; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000502:physiology; D016723:Bone Remodeling / Q000502:physiology*; D001842:Bone and Bones / Q000378:metabolism; D054439:Ghrelin / Q000097:blood / Q000502:physiology; D012739:Gonadal Steroid Hormones / Q000097:blood / Q000502:physiology; D013006:Growth Hormone / Q000097:blood / Q000502:physiology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000502:physiology; D015850:Interleukin-6 / Q000097:blood / Q000502:physiology; D009043:Motor Activity / Q000502:physiology; D011627:Puberty / Q000097:blood / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood / Q000502:physiology
D054392:Adipokines; D015415:Biomarkers; D054439:Ghrelin; D012739:Gonadal Steroid Hormones; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone